34 related articles for article (PubMed ID: 37010242)
1. Empirical Study on Exploring the Role of CD180 and MD-1 Prognostic Indicators for the Chronic Lymphocytic Leukaemia (CLL) Disease.
Alotaibi MA
Pak J Biol Sci; 2023 May; 26(6):311-320. PubMed ID: 37902045
[TBL] [Abstract][Full Text] [Related]
2. Multiplex ligation-dependent probe amplification versus multiprobe fluorescence in situ hybridization to detect genomic aberrations in chronic lymphocytic leukemia: a tertiary center experience.
Al Zaabi EA; Fernandez LA; Sadek IA; Riddell DC; Greer WL
J Mol Diagn; 2010 Mar; 12(2):197-203. PubMed ID: 20093390
[TBL] [Abstract][Full Text] [Related]
3. Cytogenetics in the management of chronic lymphocytic leukemia: Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH).
Nguyen-Khac F; Balogh Z; Chauzeix J; Veronese L; Chapiro E
Curr Res Transl Med; 2023; 71(4):103410. PubMed ID: 38039634
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological features and outcome of chronic lymphocytic leukaemia in Chinese patients.
Chan TS; Lee YS; Del Giudice I; Marinelli M; Ilari C; Cafforio L; Guarini A; Tan D; Phipps C; Goh YT; Hwang W; Goh AZ; Siu LL; Wu S; Ha CY; Lin SY; Kwok CH; Lau CK; Wong KF; Foà R; Kwong YL; Tse E
Oncotarget; 2017 Apr; 8(15):25455-25468. PubMed ID: 28424415
[TBL] [Abstract][Full Text] [Related]
5. Increased oxidative damage associated with unfavorable cytogenetic subgroups in chronic lymphocytic leukemia.
Collado R; Ivars D; Oliver I; Tormos C; Egea M; Miguel A; Sáez GT; Carbonell F
Biomed Res Int; 2014; 2014():686392. PubMed ID: 25054143
[TBL] [Abstract][Full Text] [Related]
6. Dysregulation of H/ACA ribonucleoprotein components in chronic lymphocytic leukemia.
Dos Santos PC; Panero J; Stanganelli C; Palau Nagore V; Stella F; Bezares R; Slavutsky I
PLoS One; 2017; 12(6):e0179883. PubMed ID: 28666010
[TBL] [Abstract][Full Text] [Related]
7. Characteristics and outcomes of patients with CLL and CDKN2A/B deletion by fluorescence in situ hybridization.
Teierle SM; Huang Y; Kittai AS; Bhat SA; Grever M; Rogers KA; Zhao W; Jones D; Byrd JC; Avenarius MR; Heerema NA; Woyach JA; Miller CR
Blood Adv; 2023 Dec; 7(23):7239-7242. PubMed ID: 37851900
[No Abstract] [Full Text] [Related]
8. Cytogenetic and molecular cytogenetic analysis of B cell chronic lymphocytic leukemia: specific chromosome aberrations identify prognostic subgroups of patients and point to loci of candidate genes.
Döhner H; Stilgenbauer S; Fischer K; Bentz M; Lichter P
Leukemia; 1997 Apr; 11 Suppl 2():S19-24. PubMed ID: 9178833
[TBL] [Abstract][Full Text] [Related]
9. Genetics of chronic lymphocytic leukemia: genomic aberrations and V(H) gene mutation status in pathogenesis and clinical course.
Stilgenbauer S; Bullinger L; Lichter P; Döhner H;
Leukemia; 2002 Jun; 16(6):993-1007. PubMed ID: 12040431
[TBL] [Abstract][Full Text] [Related]
10. Refining prognosis in chronic lymphocytic leukemia with normal Fluorescence in situ hybridization results.
Avenarius MR; Huang Y; Hyak J; Byrd JC; Bhat SA; Grever M; Kittai AS; Rogers KA; Jones D; Zhao W; Heerema NA; Abruzzo LV; Woyach J; Miller CR
Hematol Oncol; 2023 Oct; 41(4):771-775. PubMed ID: 37010242
[TBL] [Abstract][Full Text] [Related]
11. [Fluorescence in Situ Hybridization for Detecting Molecular Cytogenetic Abnormalities of Chronic Lymphocytic Leukemia].
Zhang HY; Yang YL; Zhao Q; Zhang J; Bai H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Oct; 28(5):1474-1479. PubMed ID: 33067940
[TBL] [Abstract][Full Text] [Related]
12. Chronic Lymphocytic Leukemia Prognostic Index: A New Integrated Scoring System to Predict the Time to First Treatment in Chinese Patients with Chronic Lymphocytic Leukemia.
Li H; Yi SH; Xiong WJ; Liu HM; Lyu R; Wang TY; Liu W; Zhong SZ; Yu Z; Zou DH; Xu Y; An G; Li ZJ; Qiu LG
Chin Med J (Engl); 2017 Jan; 130(2):135-142. PubMed ID: 28091403
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Testing Patterns and Outcomes of Chronic Lymphocytic Leukemia Patients Stratified by Fluorescence In Situ Hybridization/Cytogenetics: A Real-world Clinical Experience in the Connect CLL Registry.
Mato A; Nabhan C; Kay NE; Lamanna N; Kipps TJ; Grinblatt DL; Flowers CR; Farber CM; Davids MS; Kiselev P; Swern AS; Bhushan S; Sullivan K; Flick ED; Sharman JP
Clin Lymphoma Myeloma Leuk; 2018 Feb; 18(2):114-124.e2. PubMed ID: 29352719
[TBL] [Abstract][Full Text] [Related]
14. Immunoglobulin heavy chain (IGH@) translocations negatively impact treatment-free survival for chronic lymphocytic leukemia patients who have an isolated deletion 13q abnormality.
Gerrie AS; Bruyere H; Chan MJ; Dalal CB; Ramadan KM; Huang SJ; Toze CL; Gillan TL
Cancer Genet; 2012 Oct; 205(10):523-7. PubMed ID: 22939229
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]